|
|
|
|
Gastric Bypass Boosts Risk of Kidney Stones
(Ivanhoe Newswire) -- Gastric bypass surgery leaves patients at higher risk of developing kidney stones, a complication that may not surface until months or years after the procedure.Urinary changes that happen in weight-loss surgery patients leave them at...
|
|
|
A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With Hemodialysis
Solomon LR et al.Taurolidinecitrate use did not decrease allcause bacteremia and was associated with a greater need for thrombolytic treatment. A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of...
|
|
|
Covidien launches oral transmucosal fentanyl citrate in US
Covidien, a leading global provider of healthcare products, announced that Mallinckrodt Inc, a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country.The US Food and Drug...
|
|
|
Covidien Launches Oral Transmucosal Fentanyl Citrate Product
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country.
|
|
|
Medical News: Covidien Launches Oral Transmucosal Fentanyl Citrate Product
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country.
|
|
|
Covidien Launches Oral Transmucosal Fentanyl Citrate Product
Covidien, a leading global provider of healthcare products, announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate to distributors serving retail pharmacies across the country.The U.S. Covidien...
|
|
|
Efficacy of Letrozole in Ovulation Induction Compared to That of Clomiphene Citrate in Patients with Polycystic Ovarian Syndrome
Zeinalzadeh M et al.Efficacy of Letrozole in Ovulation Induction Compared to That of Clomiphene Citrate in Patients with Polycystic Ovarian Syndrome.
|
|
|
Covidien: Mallinckrodt launches Oral Transmucosal Fentanyl Citrate
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country.
|
|
|
Covidien Launches Oral Transmucosal Fentanyl Citrate Product
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country.
|
|
|
Covidien Launches Oral Transmucosal Fentanyl Citrate Product
LOUIS-- (BUSINESS WIRE) -- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail...
|
|
|
News and FDA Updates for China Sky One Medical (Nasdaq:CSKI), Covidien (NYSE:COV), CryoPort (OTC:CYRXD)
Pasadena, CA BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of...
|
|
|
Covidien Launches Oral Transmucosal Fentanyl Citrate Product
- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country.
|
|
|
Covidien Launches Oral Transmucosal Fentanyl Citrate Product
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country.
|
|
|
Covidien Launches Oral Transmucosal Fentanyl Citrate Product
LOUIS--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies...
|
|
|
Covidien Launches Oral Transmucosal Fentanyl Citrate Product
The product is a generic alternative to the branded ACTIQ.It is a solid formulation of fentanyl that resembles a lozenge on a handle. Oral Transmucosal Fentanyl Citrate, a Class II controlled substance, is an opioid analgesic indicated only for the...
|
|
|
Excelsior Medical's New Catheter Lock Solution Approved By Health Canada
Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe to be sold in the Canadian...
|
|
|
Excelsior Medical's New Catheter Lock Solution Approved By Health Canada
Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe to be sold in the Canadian...
|
|
|
Excelsior Medical receives Canadian marketing license for new, pre-filled catheter lock syringe
Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe to be sold in the Canadian...
|
